1990-1997 Ege University Faculty of Medicine Faculty of Medicine Undergraduate
1999-2004 Ege University Faculty of Medicine Department of Nuclear Medicine Nuclear Medicine Specialization in Medicine
Medical Specialization Thesis Title and Supervisor:
Comparative Value of Tc99m Tetrofosmin Scintimammography with Mammography, Ultrasonography and Histopathology Findings in the Study of Palpable and Nonpalpable Breast Masses
Advisor: Prof.Dr.A.Murat Argon
2004-2010 Private İzmir Şifa HospitalSpecialist
2010-2014 Şifa University Faculty of Medicine Department of Nuclear Medicine Assistant Professor Doctor
2014-2016 Şifa University Faculty of Medicine Department of Nuclear Medicine
Associate Professor Doctor
2016-2017 Çiğli Regional Training Hospital Nuclear Medicine Department,Associate Professor Doctor
2018-2020 Private City Hospital Nuclear Medicine Department, Associate Professor Doctor
2020-present Private Tınaztepe Galen Hospital, Department of Nuclear Medicine, Associate Professor Doctor
Academic Titles :
Assistant Professor Date: 25.04.2011
Associate Professorship Date: 27.01.2014
Training Period as an Overseas Observer:
1. Cleveland Clinic Department of Molecular and Functional Imaging Observership Program Cleveland/USA - 2005
2. University of Pittsburgh Department of Nuclear Medicine PET/CT Observership Program Pittsburgh/USA – 2007
Certificates of Achievement:
1. Interuniversity Board Foreign Language Exam (ÜDS) - English Health Sciences - 86.250 – 25.03.2007
2. Turkish Board of Nuclear Medicine - November 2009
3. European Board of Nuclear Medicine - May 2010
Publications :
Articles published in international peer-reviewed journals:
A1. Cokmert S, Tanriverdi O, Karapolat I, Demir L, Bayoglu V, Can A, Akyol M, Yılmaz Y, Oktay Tarhan M. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study. JBUON. 2016 Nov-Dec;21(6):1410-1418.
A2. Öztürk H, Karapolat I. 18F-fluorodeoxyglucose PET/CT for detection of disease in patients with prostate-specific antigen relapse following radical treatment of a local-stage prostate cancer. Oncol Lett. 2016 Jan;11(1):316-322.
A3. Karapolat I, Karapolat HU, Kirazli Y, Capaci K, Akkoc Y, Kumanlioglu K. Longitudinal study of bone loss in chronic spinal cord injury patients. J Phys Ther Sci. 2015 May;27(5):1429-33.
A4. Ozturk H, Karapolat I, Saklamaz A. Bilateral metachronous adrenal metastases of operated renal cell carcinoma. Urologia. 2015 Apr-Jun;82(2):114-7.
A5. Öztürk H, Karapolat I. Efficacy of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in restaging muscle-invasive bladder cancer following radical cystectomy. Exp Ther Med. 2015 Mar;9(3):717-724.
A6. Oncel G, Oncel D, Karapolat I, Sever F. The effectiveness of whole body magnetic resonance imaging (diffusion-weighted imaging and fat saturated T2-weighted imaging) in the evaluation of patients with newly diagnosed malignancies in comparison with positron emission tomography-computed tomography. JBR-BTR. 2014 Nov-Dec;97(6):341-5.
A7. Karapolat I, Sertpoyraz F, Oncel G, Kobak S, Yalcin M, Kumanlioglu K. Demonstrating disease activity in patients with rheumatoid arthritis. Is 18F FDG PET a sensitive method? Nuklearmedizin. 2013 Dec 13;52(6):244-9.
A8. Karapolat I, Kalfa M, Keser G, Yalcin M, Inal V, Kumanlioglu K, Parildar T, Aksu K. Comparison of F18 FDG PET/CT findings with current clinical disease status in patients with Takayasu's arteritis. Clin Exp Rheumatol. 2013, 31, 1, Suppl.75:0015-0021.
A9. Sanal SM, Sivrikoz ON, Karapolat I, Karademir S. Complete clinical response in squamous cell carcinoma of the rectum with liver metastases. J Clin Oncol. 2011 Nov 20;29(33):e806-8.
A10. Turker O, Karapolat I, Doğan I. A semihot-semicold but pure adenoma. Thyroid 2008;18:793.
A11. Turker O, Karapolat I. There is immunological benefit of selenium treatment in autoimmune thyroiditidis. Thyroid 2008;18:671-2.
A12. Yulug B, Bakar M, Karapolat I, Guzel O, Schäbitz WR. A case of idiopathic basal ganglia calcification presenting with only acting-out attacks and mild cognitive impairment: PET findings. J. Neuropsychiatry Clin. Neurosci. 2007;19:348-9.
A13. Yulug B, Bakar M, Karapolat I, Guzel O, Schäbitz WR. Topiramate improves glucose metabolism in choreatic and depressive patient: PET findings. J. Neuropsychiatry Clin. Neurosci. 2007;19:346-7.
A14. Akgun A, Cok G, Karapolat I, Goksel T, Burak Z. Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer. Ann. Nucl. Med. 2006;20:269-75.
A15. Turker O, Kumanlioglu K, Karapolat I, Dogan I. Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. J. Endocrinol. 2006;190:151-6.
B. Papers presented at international scientific meetings and published in the proceedings book
B1. Fidan Yildiz, Inanc Karapolat, Güray Oncel. Role of quantitative perfusion scintigraphy evaluation in determination of the efficiency of the procedure before lung volume reduction coil (LVRC) treatment for severe emphysema. European Respiratory Society International Congress, London, UK, 2016
B2. Karapolat Inanc, Sertpoyraz Filiz, Oncel Guray, Kobak Senol, Kumanlioglu Kamil. Is F-18 FDG PET a sensitive method in demonstrating disease activity in patients with rheumathoid arthritis? Second Balkan Congress of Nuclear Medicine Belgrade, Serbia, 2013.
B3. Yilmaz, E; Akkoclu, A; Gulsen, A; Sever, F; Genc, B; Kalaycioglu, S; Karapolat, I; Onen, A. Comparison of diffusion-weighted magnetic resonance imaging versus F-18 fluorodeoxyglucose positron emission tomography in the assessment of N2 lymph node metastasis due to non-small cell lung cancer. World Conference on Lung Cancer (WCLC), Sydney, Australia, 2013.
B4. Argon, M; Tani, E; Omur, O; Oral, A; Karapolat, I; Yararbas, U. The value of diffuse slow washout rate of Tl-201 in type 2 diabetes mellitus patients with and without perfusion defects in myocardial perfusion scintigraphy. 25th Annual Congress of the European Association of Nuclear Medicine (EANM), Milan, Italy, 2012.
B5. Akgun A, Yuceyar N, Karapolat I, Ozbelen Alper Y, Kocaman A. Is There any Correlation Between Fatigue in Multipl Sclerosis and Cerebral Blood Flow as Detected by Tc-99m HMPAO SPECT?. Annual Congress of the EANM, Istanbul, Turkey 2005.
B6. Akgun A, Cok G, Karapolat I, Goksel T, Burak Z. Tc-99m MIBI SPECT as an indicator of prognosis for patients with small cell lung cancer. Annual Congress of the EANM, Istanbul, Turkey 2005.
B7. Hacibeyoglu I, Ozyurt O, Asıkoglu M, Karapolat I, Tunc M. Biodistribution of F-18 FDG (fluoro-2-deoxyglucose) in rabbits. International Congress of Radiopharmacy and Radiopharmaceutical Chemistry, Istanbul, Turkey 2004.
B8. Özcan Z, Karapolat I, Dirlik A, Ömür Ö, Kumanlıoğlu K, Özkılıç H. Papillary Thyroid Carcinoma in Childhood and Adolescence. Annual Congress of the EANM, Amsterdam, Holland, 2003.
B9. Yararbaş U, Erinç R, Karapolat I, Kumanlıoğlu K. Comparison of Pinhole/High Resolution Parallel Hole and Early/Late Tc99m-MIBI Images in Parathyroid Imaging. Congress of the European Association of Nuclear Medicine, Napoli, Italy, 2001.
B10. Dirlik A, Erinç R, Burak Z, Karapolat I, Tavus S, Bacakoglu F. Assesment of alveolar epithelial permeability in diabetics using 99mTc DTPA aerosol scintigraphy. Congress of the European Assocation of Nuclear Medicine, Paris, France, 2000.
C. Articles published in national peer-reviewed journals:
C1. İnanç Karapolat. Akciğer Kanserinde Tedavi Yanıtını Değerlendirmede FDG PET/BT Görüntüleme. Nucl Med Semin 2018;4:43-51.
C2. Hatipoğlu F, Karapolat I, Ömür Ö, Akgün A, Yanarateş A, Kumanlıoğlu K. Recurrence Incidence in Differentiated Thyroid Cancers and the Importance of Diagnostic Iodine-131 Scintigraphy in Clinical Follow-up. Mol Imaging Radionucl Ther 2016 Jun 5;25(2):85-90.
C3. Mine Genc, Berhan Genc, Serap Karaarslan, Secil Kurtulmus, Seyhan Yalaz, İnanç Karapolat. Concurrent Endometrial Carcinosarcoma and Thyroid Papillary Carcinoma: PET CT Imaging Findings. Mol Imaging Radionucl Ther 2015; 24: 34-37.
C4. Karapolat I, Kumanlıoğlu K. Enfeksiyöz ve Enflamatuar Hastalıkların Pozitron Emisyon Tomografi/Bilgisayarlı Tomografi ile Görüntülenmesi. Düzce Üniversitesi Tıp Fakültesi Dergisi. 2014 16(2):63-69
C5. Karapolat I, Oncel G, Kumanlıoğlu K. Clinically Occult Pituitary Adenoma Can Appear as a Hypermetabolic Lesion on Whole Body FDG PET Imaging in a Patient with Lymphoma. Mol Imaging Radionucl Ther. 2013 Apr;22(1):18-20.
C6. Karapolat I, Kumanlıoğlu K. Impact of FDG-PET/CT for the Detection of Unknown Primary Tumours in Patients with Cervical Lymph Node Metastases. Mol Imaging Radionucl Ther. 2012 Aug;21(2):63-8.
C7. Cok G, Karapolat I, Turhan K, Göksel T, Cakan A, Nart D, Kumanlıoğlu K. Akciğer Kanserlerinin Tanı ve Evrelemesinde Pozitron Emisyon Tomografisinin Tanısal Değeri. Solunum 2006; Vol: 8 Sayı: 2 Sayfa: 55-59.
C8. Yıldız F, Özyurt Ö, Karapolat I, Oncel G, Kumanlıoğlu K, Oncel D. Erken Evre Akciğer Kanseri Olgularımızın Klinik ve Görüntüleme Bulguları (Radyoloji ve PET). Turk. J. Nuc. Med. 2007, 16.
C9. Kömürcülü N, İnce A, Bakar E, Yılmaz H, Karapolat I, Selçuki D. Huntington Hastalığı: İki Olgu. Ege Tıp Dergisi 45 (2): 139-143, 2006.
C10. Özgür Ö, Özcan Z, Akgün A, Karapolat İ, Özkılıç H. Papillary microcarcinoma of the thyroid gland presenting initially with regional or distant metastasis. Turk. J. Nucl. Med. 2005, Volume 14, No:4.
C11. Özgür Ö, Karapolat İ. Kalsifikasyon odağı saptanmayan metastatik karaciğer lezyonunda Tc99m MDP tutulumu. Turk. J. Nucl. Med. 2002, Volume 11, No:4.
D. Papers presented at national scientific meetings and published in the proceedings book:
D1. Fidan Sever, Aşkın Gülşen, Ayşe Pelin Girgin, Filiz Hatipoğlu, İnanç Karapolat, Güray Öncel. Bronkoskopik Volüm Azaltıcı Sarmal tedavisi (LVRC) öncesi V/Q Sintigrafi değerlendirmesinin işlemin etkinliğini belirlemedeki rolü. TÜSAD 37. Ulusal Kongresi. İzmir, Türkiye, Ekim 2015
D2. Karapolat I, Sertpoyraz F, Öncel G, Kobak Ş, Kumanlıoğlu K. F-18 FDG PET-BT Romatoid Artrit Hastalarında Hastalık Aktivitesini Göstermede Duyarlı Bir Yöntem midir?. 25. Ulusal Nükleer Tıp Kongresi, Antalya, Türkiye, 2013
D3. Çerçi U, Bozdemir E, Karapolat I. Servikal Lenf Bezi Metastazı olan Hastalarda Primer Odak Araştırılmasında FDG PET/BT'nin Etkinliği, 34. Türk Ulusal Kulak Burun Boğaz ve Baş Boyun Cerrahisi Kongres,. Antalya, Türkiye, Ekim 2012
D4. Yalçın M, Karadeniz M, Genç B, Öncel G, Karapolat I, Sever F. Mediastende Ektopik Paratiroid Adenomu ve Ciddi Vitamin D3 Eksikliği Olan Olgu. İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri, İstanbul, Türkiye, Mart 2012
D5. Yalçın M, Sivrikoz O, Karaarslan S, Karapolat I, Sanal S. Meme ve Paratiroid Kanseri Birlikteliği Olan Bir Olgu. İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri, İstanbul, Türkiye, Mart 2012
D6. Yalçın M, Karadeniz M, Sanal S, Demir Ö, Karapolat I, Gökduman A, Buğdaycı H, Arıcan A, Kırcı A. Pankreas Başında Yerleşmiş Tıkanma Sarılığı ve Kan Şekeri Yükselmesiyle Teşhis Edilen Granülositik Sarkom Olgusu. İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri, İstanbul, Türkiye, Mart 2012
D7. Argon M, Yararbaş U, Karapolat I. PET-BT’de Hatalı Pozitiflik Nedenlerinden Biri: Sarkoidoz, 23. Ulusal Nükleer Tıp Kongresi, İzmir, Türkiye, 2011
D8. Sivrikoz N.O, Karaarslan S, Karapolat I. Primer Tiroid Angiosarkomu: Olgu Sunumu, 21. Ulusal Patoloji Kongresi, İzmir, Türkiye, 2011
D9. Karapolat I, Özyurt Ö, Kumanlıoğlu K, Kuşçu B. Yaygın akciğer tüberkülozlu bir olguda PET/BT bulguları. 21. Ulusal Nükleer Tıp Kongresi, Antalya, Türkiye 2009.
D10. Karapolat I, Özyurt Ö, Kumanlıoğlu K, Uyar M. Orbital lenfomalı bir olguda PET/BT ile evreleme ve tedaviye yanıtın değerlendirilmesi. 21. Ulusal Nükleer Tıp Kongresi, Antalya, Türkiye 2009.
D11. Özyurt Ö, Karapolat I, Kumanlıoğlu K, Hacıbeyoğlu I, Tunç M. PET çalışmasında Geç Görüntünün Önemi; Serviks Karsinomu Tanılı Olgunun Tedavi Sonrası Değerlendirilmesi. Nükleer Tıp Sempozyumu Pozitron Emisyon Tomografi konferansı, Ankara, Türkiye, Mart 2005
D12. Özyurt Ö, Karapolat I, Kumanlıoğlu K, Hacıbeyoğlu I, Tunç M. Metastaz Taraması Nedeniyle PET Tetkiki Yapılan ve Tesadüfen Primer Tiroid Malignitesi Saptanan Olgu. Nükleer Tıp Sempozyumu Pozitron Emisyon Tomografisi konferansı, Ankara, Türkiye, Mart 2005
D13. Dirlik A, Çok G, Karapolat I, Göksel T, Burak Z. Küçük hücreli akciğer kanserinde kemoterapi yanıtını önceden belirlemede Tc99m MIBI SPECT. 16. Ulusal Nükleer Tıp Kongresi, Samsun, Türkiye 2003.
D14. Karapolat I, Özcan Z, Dirlik A, Ömür Ö, Kumanlıoğlu K, Özkılıç H. Çocukluk çağında papiller tiroid kanserleri. 16. Ulusal Nükleer Tıp Kongresi, Samsun, Türkiye 2003.
D15. Dirlik A, Karapolat I, Göksel T, Özcan Z, Burak Z. Comparison of Tc-99m MIBI uptake ratios in lung cancer using two different regions of interests. 15.Ulusal Nükleer Tıp Kongresi, Kuşadası, Türkiye 2002.
Memberships to Scientific and Professional Organizations:
Turkish Medical Association Izmir Medical Chamber
Turkish Nuclear Medicine Association
European Nuclear Medicine Association